Skip to Main Content

Antiviral Chemotherapy

Remdesivir is approved for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hospitalized patients.

In a multinational, randomized trial, hospitalized patients infected with SARS-CoV-2 who received remdesivir showed a significant reduction in the time to recovery compared to those who received placebo; those requiring supplemental oxygen benefited the most from remdesivir treatment.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.